BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
cell-cell adhesion
,
Inflammatory disorder
,
Intestine
,
DNA fingerprint
,
Quercetin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
1 5- isoquinolinesulfonyl)- 2- methylpiperazine
Summary
General Info
Curated Studies
Most Correlated Studies
Comparison of mouse epithelial vs mesenchymal tumor stem cells
Pancreatic progenitors (INS+) derived from HES-3 ES cells after treatment with H-1152
Actomyosin contractility and its effect on tumor cell gene expression
Lung cancer A549 cells (KRAS mutant) after BI-2536 and fasudil combination treatment
Diffuse Large B-Cell Lymphoma OCI-LY3 cells time-course/dose response treatment with 14 drug panel
Explore Curated Studies Results
Literature
Most Relevant Literature
Effect of H-7 on secondary cataract after phacoemulsification in the live rabbit eye.
Specific IgE to peanut 2S albumin Ara h 7 has a discriminative ability comparable to Ara h 2 and 6.
Cytoskeletal drugs prevent posterior capsular opacification in human lens capsule in vitro.
5-Fluoro-6'H,7'H,8'H-spiro-[indoline-3,7'-pyrano[3,2-c:5,6-c']di-1-benzopyran]-2,6',8'-trione.
Fasudil and its analogs: a new powerful weapon in the long war against central nervous system disord…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Fasudil fOr redUcing elopemeNt and Spatial Disorientation
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ